Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
New HIV therapy reduces virus, boosts immunity in drug-resistant patients

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.

Published
2 hours ago
From
Science Daily
One in nine people may be able to control their viral load after stopping treatment, US study finds

A US collaboration that pooled data from 14 scientific studies containing between them more than 600 HIV-positive people has found that 67 of them were able to

Published
3 hours ago
By
Gus Cairns
ViiV, Janssen’s two-drug HIV regimen hits PhIII targets

ViiV Healthcare and Janssen have unveiled positive headline data from a late-stage trial of their injectable two-drug regimen for the treatment of HIV.

Published
15 August 2018
From
Pharma Times
Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

Lynn Mofenson, M.D., who is a researcher with the Elizabeth Glaser Pediatric AIDS Foundation, explains what is known about the potential risk of neural tube defects when dolutegravir is used around the time of conception.

Published
15 August 2018
From
The Body PRO
Studies show dolutegravir monotherapy is an unsafe switch option

Using dolutegravir alone, as maintenance treatment after achieving undetectable viral load on a three-drug regimen, results in an unacceptable rate of viral rebound and is unethical in

Published
09 August 2018
By
Keith Alcorn
Diarrhoea continues to affect the quality of life of people with HIV in the modern treatment era

A meta-analysis of 38 clinical trials of antiretroviral therapies (ART) conducted in the past decade found that an average of 17% of study participants suffered from diarrhoea,

Published
07 August 2018
By
Roger Pebody
How Will Long-Acting HIV Antiretrovirals Work in the Real World?

While there has been considerable buzz within the HIV workforce about the promise of long-acting antiretrovirals to transform both HIV prevention and treatment, a critical question hangs in the air: Once viable long-acting options have reached the market, what will be their true impact? Will they really help move us toward an HIV-free world?

Published
01 August 2018
From
The Body Pro
‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people

When Science published a monkey study nearly 2 years ago that showed an anti-inflammatory antibody effectively cured monkeys intentionally infected with the simian form of the AIDS virus, the dramatic results turned many heads. But some skeptical researchers thought the data looked too good to be true and predicted the intervention wouldn’t work on HIV in humans. They were right.

Published
30 July 2018
From
Science
Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 weeks of follow-up

The experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) doravirine was more effective than darunavir/ritonavir over nearly two years of follow-up, according to results of a phase

Published
30 July 2018
By
Michael Carter
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed

A daily dose of the boosted protease inhibitor darunavir/ritonavir 400/100mg is at least as effective as therapy with lopinavir/ritonavir for people switching treatment while virally

Published
30 July 2018
By
Michael Carter
← First12345...477Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.